ArticleFrontiers in endocrinology2026

On-treatment change in bone turnover markers predicts 2-year bone mineral density after sequential therapy following romosozumab: a real-world cohort study.

Ryo Nakano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.